We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

News

EZCORP CTO Fugitt Receives 11,761 RSUs in Nov 2026

James W. Fugitt, Chief Technology Officer of EZCORP INC (NASDAQ:EZPW), filed a Form 4 on November 12, 2026, reporting the acquisition of 11,761 restricted stock units on November 10, 2026.

Anjali Anand | 12 November 2026

Boost Run Q3 2026 Earnings Results Disclosed

Boost Run Inc. filed a Form 8-K with the SEC on November 12, 2026, announcing the release of its financial and operational results for the quarter ended September 30, 2026, along with accompanying earnings conference call materials.

Aakashdeep | 12 November 2026

Lucy Hernandez Receives 5,040 RSUs from EZCORP

EZCORP Inc. Chief Operations Admin Officer Lucy Hernandez filed a Form 4 on November 12, 2026, disclosing the acquisition of 5,040 Restricted Stock Units on November 10, 2026, tied to Class A Non-Voting Common Stock.

Nitish Kishor | 12 November 2026

DuPont Partners With Microsoft and NobleAI on R&D AI Tools

DuPont announced a collaboration with Microsoft and NobleAI on November 12, 2026, aimed at expanding access to AI tools, including machine learning, to help its scientists and engineers accelerate innovation and reduce cycle times for delivering customer solutions.

Vinay Lochav | 12 November 2026

Adage Capital Discloses 6.68% Stake in Camp4 Therapeutics

Adage Capital Management, L.P., together with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G on November 12, 2026, reporting beneficial ownership of 4,190,023 shares of common stock in Camp4 Therapeutics Corporation, a Delaware-incorporated biotherapeutics company headquartered in Watertown, Massachusetts.

Aakashdeep | 12 November 2026

Adage Capital Discloses 7.06% Stake in Xilio Therapeutics

Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G with the SEC on November 12, 2026, disclosing beneficial ownership of shares in Xilio Therapeutics, Inc. as of September 30, 2026.

Aditi Sarkar | 12 November 2026

Adage Capital Discloses 8.42% Stake in AMR Resources

Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G with the SEC on November 12, 2026, disclosing beneficial ownership of Class A Ordinary Shares of AMR Resources Acquisition Corp. as of September 30, 2026.

Vinay Lochav | 12 November 2026

Adage Capital Discloses 6.79% Stake in Korro Bio

Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G with the SEC on November 12, 2026, disclosing beneficial ownership of 1,000,000 shares of Korro Bio, Inc. common stock as of September 30, 2026.

Vinay Lochav | 12 November 2026

Adage Capital Discloses 7.83% Stake in Live Oak VI

Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G on November 12, 2026, disclosing beneficial ownership of 1,800,000 Class A Ordinary Shares of Live Oak Acquisition Corp. VI as of September 30, 2026.

Manish Choudhary | 12 November 2026

Adage Capital Discloses 7.86% Stake in Ares Acquisition Corp III

Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G with the SEC disclosing a 7.86% beneficial ownership position in Ares Acquisition Corp III's Class A Ordinary Shares, with a triggering event date of September 30, 2026.

Nitish Kishor | 12 November 2026
Support

Hi! How can we help you today?

Loading…